Approval · Notice of Compliance 20707 · 2018
COMPONENT TE-200 IMPLANTS: Notice of Compliance 20707
Issued April 9, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20707
- Date
- April 9, 2018
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative - Merger/Buyout
- Canadian reference product
- REVALOR 200 (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT TE-200 IMPLANTS | 02366908 | Dormant |
Medicinal ingredients
- ESTRADIOL 20 MG per IMP
- TRENBOLONE ACETATE 200 MG per IMP